Biosurgery products are used to aid surgeries and repair weakened and damaged tissues and bones of a body. The biosurgery market is majorly driven by the rising number of surgeries owing to the increasing rate of obesity and other lifestyle disorders, increasing participation in sports leading to sports-related injuries, and growing aging population. However, lack of reimbursement for these products and the increasing cost of surgical procedures are expected to restrain the growth of this market during the forecast period.

The biosurgery market in this report is broadly segmented on the basis of type and application. On the basis oftype, the market is segmented into sealants, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple-line reinforcement agents. On the basis of application, the market is segmented into neurological surgeries, cardiovascular surgeries, general surgeries, orthopedic surgeries, thoracic surgeries, gynecology surgeries, urology surgeries, and reconstructive surgeries.
The global biosurgery market is expected to reach $25,635.01million by 2020, growing at a CAGR of 8.8% during the forecast period (2015 to 2020). Rising investments in R&D leading to development of innovative products in this space is propelling the growth of this market. Biosurgery products are finding increasing applications in neurological surgeries.

Developed markets like North America and Europe will show sluggish growth, while emerging markets like Asia-Pacific and RoW (Latin America) are expected to witnessstrong growth during the forecast period. Growth in the Asia-Pacific and RoW marketswill be majorly driven by countriessuch asChina, Korea, Russia, and Brazil owing to the rising government investments in these countries, presence of a large patient population, and the increasing focus of leading players to capture growth opportunities in these markets.

Some of the prominent players in this market include Baxter International Inc. (U.S.), C.R. Bard (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Sanofi Group (France), B. Braun Melsungen AG (Germany), Atrium Medical Corporation (U.S.), Cryolife, Inc. (U.S.), Stryker Corporation (U.S.), and Hemostasis, LLC (U.S.). Mergers and acquisitions, expansions, and new product launches are some of the strategies adopted by these players to sustain and enhance their presence in this market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below-mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios offered by top players in the biosurgery market. The report analyzes the biosurgery market by type and application
• Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the biosurgery market
• Market Development: Comprehensive information about lucrative emerging markets by product, application, and region
• Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the biosurgery market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, products, manufacturing capabilities, and SWOT analyses of leading players in the biosurgery market

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Growth Potential for the Market of Biosurgery
4.2 Asia-Pacific: Biosurgery Market, By Product (2014)
4.3 Biosurgery Market: Geographic Growth Opportunities
4.4 Biosurgery Market, Regional Mix
4.5 Biosurgery Market: Developed vs Developing Countries

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 By  Type
5.2.2 By Application
5.3 Market Dynamics
5.4 Market Drivers
5.4.1 Rising Number of Surgeries
5.4.2 Increasing Incidence of Sports-Related Injuries and Spinal Problems
5.4.3 Rapid Rise in Aging Population
5.5 Market Restraints
5.5.1 Little-To-No Reimbursements for Biosurgery
5.6 Market Opportunities
5.6.1 Improving Healthcare Systems in Emerging Markets With Growing Public & Private Investments
5.7 Market Challenges
5.7.1 High Price of Biosurgery & Rising Cost of Surgical Procedures

6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Growing Preference for Biological Meshes in Surgerical Procedures
6.2.2 Increasing Acquisitions in Biosurgery Market Leads to Consolidation in the Market
6.3 Porter’s Five Forces Analysis
6.3.1 Threat From New Entrants
6.3.2 Threat From New Substitutes
6.3.3 Bargaining Power of Suppliers
6.3.4 Bargaining Power of Buyers
6.3.5 Intensity of Competitive Rivalry
6.4 Strategic Benchmarking
6.4.1 Product Portfolio Analysis: Biosurgery Market

7 Biosurgery Market, By Product
7.1 Introduction
7.2 Surgical Sealants
7.2.1 Fibrin Sealants
7.2.2 Synthetic Agents/Cyanoacrylates
7.2.3 Collagen-Based Sealants
7.2.4 Tissue Adhesive Glues
7.3 Hemostatic Agents
7.4 Adhesion Barriers
7.5 Soft-Tissue Attachments (Soft Tissue Patch/Mesh)
7.5.1 Synthetic Mesh
7.5.2 Biological Mesh
7.5.2.1 Allografts
7.5.2.2 Xenografts
7.6 Bone Graft Subsitutes
7.6.1 Bone Allografts
7.6.2 Demineralized Bone Matrix (DBM)
7.6.3 Bone Morphogenetic Proteins (BMP)
7.6.4 Synthetic Bone Grafts
7.7 Staple Line Reinforcement Agents

8 Biosurgery Market, By Application Key Findings
8.1 Introduction
8.2 Neurological Surgeries
8.3 Cardiovascular Surgeries
8.4 General Surgeries
8.5 Orthopedic Surgeries
8.6 Thoracic Surgeries
8.7 Gynecology Surgeries
8.8 Urology Surgeries
8.9 Reconstructive Surgeries

9 Biosurgery Market, By Geography Key Findings
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe (RoE)
9.4 Asia-Pacific (APAC)
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific (ROAPAC)
9.5 Rest of the World (RoW)
9.5.1 Latin America
9.5.2 Middle East and Africa

10 Competitive Landscape
10.1 Overview
10.2 Market Share of Biosurgery
10.2.1 Sealants, Hemostatic Agents, Adhesion Barriers, and Staple-Line Reinforcement Agents
10.2.2 Bone-Graft Substitutes
10.2.3 Soft-Tissue Attachments (Tissue Patch/Mesh)
10.3 Competitive Situation and Trends
10.3.1 Mergers and Acquisitions
10.3.2 Others
10.3.3 Expansions
10.3.4 New Product Launches
10.3.5 Agreements, Partnerships, and Alliances

11 Company Profiles
11.1 Introduction
11.2 Baxter International Inc.
11.2.1 Business Overview
11.2.2 Product Offerings
11.2.3 Recent Developments
11.2.4 SWOT Analysis
11.2.5 MnM View
11.3 Johnson & Johnson
11.3.1 Business Overview
11.3.2 Product Offerings
11.3.3 Recent Developments
11.3.4 SWOT Analysis
11.3.5 MnM View
11.4 C.R. BARD, Inc.
11.4.1 Business Overview
11.4.2 Products & Services
11.4.3 Recent Developments
11.4.4 SWOT Analysis
11.4.5 MnM View
11.5 Covidien PLC.
11.5.1 Business Overview
11.5.2 Product Offerings
11.5.3 Recent Developments
11.5.4 SWOT Analysis
11.5.5 MnM View
11.6 Sanofi Group
11.6.1 Business Overview
11.6.2 Product Offerings
11.6.3 Recent Developments
11.6.4 SWOT Analysis
11.6.5 MnM View
11.7 B. Braun Melsungen AG
11.7.1 Business Overview
11.7.2 Product Offerings
11.7.3 Recent Developments
11.8 Atrium Medical Corporation (A Part of Getinge Group)
11.8.1 Business Overview
11.8.2 Product Offerings
11.8.3 Recent Developments
11.9 Cryolife, Inc.
11.9.1 Business Overview
11.9.2 Product Offerings
11.9.3 Recent Developments
11.10 Hemostasis, LLC
11.10.1 Business Overview
11.10.2 Product Offerings
11.11 Stryker Corporation
11.11.1 Business Overview
11.11.2 Product Offerings
11.11.3 Recent Developments

12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Introducing Rt: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports

*Details on Key Financials and Growth Strategy Might Not Be Captured in Case of Unlisted Companies.

List of Tables

Table 1 Rising Number of Surgical Procedures & Increasing Number of Sports-Related Injuries Expected to Drive the Growth of the Biosurgery Market
Table 2 Little-To-No Reimbursements for Biosurgery to Hinder the Growth of the Market
Table 3 Improving Healthcare Systems in Emerging Markets With Growing Investments Offer Significant Growth Opportunities
Table 4 High Price of the Biosurgery and Rising Cost of Surgical Procedures: Market Challenges
Table 5 Global Biosurgery Market Size, By Product, 2013–2020 ($Million)
Table 6 Global Biosurgery Market Size for Surgical Sealants, By Product Type, 2013–2020 ($Million)
Table 7 Global Surgical Sealants Market Size, By Country, 2013–2020 ($Million)
Table 8 Global Fibrin Sealants Market Size, By Country, 2013–2020 ($Million)
Table 9 Global Synthetic Agents/Cyanoacrylates Market Size, By Country, 2013–2020 ($Million)
Table 10 Global Collagen-Based Sealants Market Size, By Country, 2013–2020 ($Million)
Table 11 Global Tissue Adhesive Glues Market Size, By Country, 2013–2020 ($Million)
Table 12 Global Hemostatic Agents Market Size , By Country, 2013–2020 ($Million)
Table 13 Global Adhesion Barriers Market Size , By Country, 2013–2020 ($Million)
Table 14 Global  Soft-Tissue Patches/Meshes Market Size, By Product Type, 2013–2020 ($Million)
Table 15 Global Soft Tissue Patches/Meshes Market Size, By Country, 2013–2020 ($Million)
Table 16 Global Synthetic Mesh Market Size, By Country, 2013–2020 ($Million)
Table 17 Global Biological Mesh Market Size , By Product Type, 2013–2020 ($Million)
Table 18 Global Biological Mesh Market Size, By Country, 2013–2020 ($Million)
Table 19 Global Allografts Market Size , By Country, 2013–2020 ($Million)
Table 20 Global Xenografts Market Size , By Country, 2013–2020 ($Million)
Table 21 Global Bone Graft Substitutes Market Size, By Product Type, 2013–2020 ($Million)
Table 22 Global Bone Graft Substitutes Market Size, By Country, 2013–2020 ($Million)
Table 23 Global Bone Allografts Market Size, By Country, 2013–2020 ($Million)
Table 24 Global DBM Market Size, By Country, 2013–2020 ($Million)
Table 25 Global BMP Market Size, By Country, 2013–2020 ($Million)
Table 26 Global Synthetic Bone Grafts Market Size, By Country, 2013–2020 ($Million)
Table 27 Global Staple Line Reinforcement Agents Market Size, By Country, 2013–2020 ($Million)
Table 28 Global Biosurgery Market Size, By Application, 2013–2020 ($Million)
Table 29 Global Biosurgery Market Size for Neurological Surgeries, By Country/Region, 2013–2020 ($Million)
Table 30 Global Market Size for Cardiovascular Surgeries, By Country/Region, 2013–2020 ($Million)
Table 31 Global Biosurgery Market Size for General Surgeries, By Country/Region, 2013–2020 ($Million)
Table 32 Global Biosurgery Market Size for Orthopedic Surgeries, By Country/Region, 2013–2020 ($Million)
Table 33 Global Biosurgery Market Size for Thoracic Surgeries, By Country/Region, 2013–2020 ($Million)
Table 34 Global Biosurgery Market Size for Gynecology Surgeries, By Country/Region, 2013–2020 ($Million)
Table 35 Global Market Size for Urology Surgeries, By Country/Region, 2013–2020 ($Million)
Table 36 Global Market Size for Reconstructive Surgeries, By Country/Region, 2013–2020 ($Million)
Table 37 Global Biosurgery Market, By Region, 2013-2020 ($ Million)
Table 38 North America: Biosurgery Market Size, By Country, 2013-2020 ($ Million)
Table 39 North America: Market Size, By Product Type, 2013-2020 ($Million)
Table 40 North America: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 41 U.S.: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 42 U.S.: Market Size, By Application, 2013-2020 ($Million)
Table 43 Canada: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 44 Canada: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 45 Europe: Biosurgery Market Size, By Country, 2013-2020 ($ Million)
Table 46 Europe: Market Size, By Product, 2013-2020 ($Million)
Table 47 Europe: Market Size, By Application, 2013-2020 ($Million)
Table 48 Germany: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 49 Germany: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 50 U.K.: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 51 U.K.: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 52 France: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 53 France: Market Size, By Application, 2013-2020 ($Million)
Table 54 Italy: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 55 Italy: Market Size, By Application, 2013-2020 ($Million)
Table 56 Spain: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 57 Spain: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 58 RoE: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 59 RoE: Market Size, By Application, 2013-2020 ($Million)
Table 60 APAC: Biosurgery Market Size, By Country, 2013-2020 ($ Million)
Table 61 APAC: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 62 APAC: Market Size, By Application, 2013-2020 ($Million)
Table 63 Japan: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 64 Japan: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 65 China: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 66 China: Market Size, By Application, 2013-2020 ($Million)
Table 67 India: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 68 India: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 69 ROAPAC: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 70 ROAPAC: Market Size, By Application, 2013-2020 ($Million)
Table 71 RoW: Biosurgery Market Size, By Country, 2013-2020 ($ Million)
Table 72 RoW: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 73 RoW: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 74 Latin America: Biosurgery Market Size, By Product, 2013-2020 ($Million)
Table 75 Latin America: Biosurgery Market Size, By Application, 2013-2020 ($Million)
Table 76 Middle East and Africa: Market Size, By Product, 2013-2020 ($Million)
Table 77 Middle East and Africa: Market Size, By Application, 2013-2020 ($Million)
Table 78 Growth Strategy Matrix, 2011 – 2015
Table 79 Mergers and Acquisitions, 2011 – 2015
Table 80 Others, 2011 – 2015
Table 81 Expansions, 2011 - 2015
Table 82 New Product Launches, 2011 – 2015
Table 83 Agreements, Partnerships, and Alliances, 2011 – 2015

List of Figures

Figure 1 Global Biosurgery Market
Figure 2 Research Design for Biosurgery
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global Biosurgery Market, By Product Type, 2015 vs 2020 ($ Million)
Figure 8 Global Biosurgery Products Market Size, By Application, 2015 vs 2020 ($ Million)
Figure 9 Geographical Snapshot of the Biosurgery Market, 2014
Figure 10 North America Dominated the Global Biosurgery Market in 2014
Figure 11 Rising Number of Surgeries to Drive Market Growth for Biosurgery
Figure 12 Soft-Tissue Attachment Market Accounted for Major Share of the Asia-Pacific Biosurgery Market
Figure 13 The U.S. Commanded the Largest Share of the Biosurgery Market in 2014
Figure 14 North America to Dominate the Biosurgery Market During the Forecast Period
Figure 15 Developing Markets to Register A Higher Growth During the Forecast Period
Figure 16 Biosurgery Market Segmentation, By  Type
Figure 17 Biosurgery Market Segmentation, By Application
Figure 18 Biosurgery Market: Drivers, Restraints, Opportunities, & Challenges
Figure 19 Demographic Growth Trends of the Elderly Population
Figure 20 Increasing Trend Towards Use of Biological Meshes and Acquisitions By Major Players Leading to Rising Consolidations in Biosurgery Market
Figure 21 Companies Adopted Expansions as Their Key Growth Strategy
Figure 22 Global Sealants, Hemostatic Agents, Adhesion Barriers, and Staple-Line Reinforcement Market Share Analysis, By Key Players, 2014
Figure 23 Global Bone Graft-Substitutes Market Share Analysis of Biosurgery, By Key Players, 2014
Figure 24 Global Soft-Tissue Repair Market Share Analysis of Biosurgery, By Key Player, 2014
Figure 25 Battle for Market Share of Biosurgery: Mergers and Acquisitions Was the Key Strategy Adopted By Prominent Players
Figure 26 Geographic Revenue Mix of Major Players
Figure 27 Company Snapshot: Baxter International Inc.
Figure 28 Company Snapshot: Johnson & Johnson
Figure 29 Company Snapshot: C.R. BARD, Inc.
Figure 30 Company Snapshot: Covidien PLC.
Figure 31 Company Snapshot: Sanofi Group
Figure 32 Company Snapshot: B. Braun Melsungen AG
Figure 33 Company Snapshot: Getinge Group
Figure 34 Company Snapshot: Cryolife, Inc.
Figure 35 Company Snapshot: Stryker Corporation